Are you looking for a temporary science job in the North East or Scotland? Meet Graeme Pallas….
You can contact Graeme on 0119 384 8905 or email gpallas@ckscience.co.uk.
Are you looking for a temporary science job in the North East or Scotland? Meet Graeme Pallas….
You can contact Graeme on 0119 384 8905 or email gpallas@ckscience.co.uk.
BBC News reported that two-thirds of the workers who left the Pfizer site in Kent after being made redundant last year have found other jobs. This comes after the company unfortunately last year had to close some of its Kent based site which employed 2400 people. Pfizer said that it would keep 650 jobs in Kent and 250 at other UK sites. Speaking about the workers who had found work elsewhere, Dr Annette Doherty, site leader for Pfizer Sandwich, said some workers remained in the biomedical sector while others had left Kent and moved to other roles.
Pfizer said it had tried to monitor the impact of the closure announcement on colleagues and based on the voluntary responses of more than 1,000 people leaving the company had estimated that about two-thirds had left for new opportunities.
It also was reported last week that Pfizer was in detailed talks with a consortium led by London and Metropolitan about buying the site. Dr Doherty said that if the sale went ahead, London and Metropolitan would become the site owner and would rent space to other companies. Pfizer would remain, running a smaller operation in rented buildings, and three other science and technology companies were also moving in.
Laura Sandys, Conservative MP for South Thanet and Sandwich, said: “While there are still staff who have not found jobs and companies in the area who were reliant on Pfizer, almost 1,000 jobs are now secure and a new buyer for the site is in final negotiations. What seemed like a disastrous day a year ago looks a lot more promising.”
Hannah Milward is currently recruiting for a Quality Assurance Representative to join a global manufacturer of pharmaceutical and veterinary medicine products based in the Merseyside region. They require a Contract Quality Assurance Representative to join their team for an initial period of 12 months.
The successful candidate for this Quality Assurance Representative will provide the Quality Assurance Team the assurance that manufacturing is carried out in accordance with cGMP and Regulatory commitments and that production records provide full and accurate documentation of batch manufacture in accordance with SOP. The QAR is authorised, as appropriate, by the QA Team Leader to disposition materials with consideration being given to the Regulatory requirement for QP release of veterinary and medicinal products. The job holder also exercises control on the general cGMP activities for those teams he/she has QA responsibility for.
The responsibilities of this Quality Assurance Representative role will include:
• Disposition raw materials, including packaging items, water, intermediates and products according to the available data, including evaluation of any deviation reports, environmental monitoring (where appropriate), and advise on reprocessing or preventive actions in such cases.
• Monitor trends and identify problems in quality of purchased materials, packaging, intermediates, products, water and environmental data and promote action having regard to changes in processes, facilities, equipment and procedures.
• Write/revise/approve and give advise on quality documentation e.g. batch production records, specifications, procedures (Team and Site), PMISsheets, Stability protocols.
• Review and approve SOPs (Team and Site), change control documentation, validation protocols, completed validation packages, IQ/OQ/PQ protocols.
• Manage the Site stability programme to meet Corporate and Regulatory requirements.
• To advise on the investigation of customer complaints, approve customer complaint reports and promote corrective/preventive actions
• Participate in self-inspections and other audits of the manufacturing and relevant Support areas with particular reference to cGMP as defined by the various regulatory authorities.
• Provide training, support, advice and proactive assistance in the Site Quality systems to the product and support teams.
• Advise on and support appropriate validation of plant, processes and new projects, liaising with other disciplines appropriately to ensure that facilities are designed and commissioned to meet cGMP.
• Provide cover for other QARs in their absence.
• Prepare Quality Agreements as appropriate.
• Liaise with Contract Manufacturers, as appropriate, to ensure that the Quality systems at the Contract Manufacturers comply with Corporate/Regulatory requirements and that the Quality systems are being implemented appropriately.
To be considered for this Quality Assurance Representative position you will have experience working in a similar role reviewing and supplying batch record documentation to the QP for release. You will also have experience working in the Pharmaceutical industry.
For more information or to apply for this Quality Assurance Representative role please contact Hannah Milward on 0114 2839956 or email hmilward@ckscience.co.uk. Please quote reference SH23570 in all correspondence.
GlaxoSmithKline (GSK) released a press statement this week announcing that it has joined other global pharmaceutical companies and leading organisations such as the World Health Organization (WHO), the Bill & Melinda Gates Foundation, the UK Department for International Development and the US Agency for International Development (USAID) in an effort to support developing countries to defeat neglected tropical diseases (NTDs). Neglected tropical diseases affect more than one billion people in developing countries, causing illness, disability and death, and increasing the burden on over-stretched health systems.
This united group will support the goals given this week by the WHO to control or eliminate ten of the 17 diseases designated as neglected tropical diseases by the end of the 2020. This includes eliminating five diseases: lymphatic filariasis (elephantiasis), guinea worm, blinding trachoma, sleeping sickness and leprosy, and controlling a further five: soil transmitted helminthes (intestinal worms), schistosomiasis, river blindness, Chagas and visceral leishmaniasis by 2020.
The CEO of GSK, Sir Andrew Witty said: “I am delighted to announce that GSK is part of this united effort to free future generations from the burden of neglected tropical diseases. We fully support the WHO’s bold vision and we are committed to playing our part in helping to achieve universal coverage of intervention programmes for diseases that can be controlled or eliminated by existing treatments, and to spur R&D into new treatments for diseases where none currently exist. Through this new partnership, we have both the means and the energy to strike a decisive blow against disease in the world’s poorest countries.”
Andrew Bolton at CK Science is currently looking for a Toxicologist to join a world leading Chemical Manufacturer, who specialises in chemicals for the industrial, automotive & related markets. They are currently looking for a Toxicologist to join their Regulatory Team based from their state-of-the-art facilities in Oxfordshire.
This Toxicologist role is an outstanding opportunity to join a Chemical Manufacturer at the forefront of their field. The organisation is willing to consider candidate’s at various levels, offering in return a negotiable salary depending on experience and excellent benefits.
As a Toxicologist, you will be part of a team providing toxicology & regulatory support to new & existing product development teams worldwide. Your duties will include:
To be considered for this Toxicologist role, you will have demonstrated experience within a Toxicologist position gained within a Chemical industry. Working knowledge of REACH would be advantageous, but it is not essential.
For more information or to apply for this Toxicologist role please contact Andrew Bolton on 01438 723 500 or email abolton@ckscience.co.uk. Please quote reference ST23552 in all correspondence.
Barney Smith at CK Science is recruiting for a Product development Chemist to join a company that manufactures novel products for the Oil & Gas industry.
As a Product development Chemist you will be responsible for developing rubber based polymers to customer specifications and requirements. This will include developing polymers from scratch, developing existing products, compounding, sourcing and maintaining test equipment and providing technical support to clients.
The ideal candidate for this Product development Chemist must be qualified to PhD in organic or polymer chemistry standard or possess equivalent commercial laboratory experience within rubber or plastics development. They must also possess working knowledge of instrumentation and equipment used in rubber development and compounding and your communication skills must be excellent.
For more information or to apply for this Product development Chemist role please contact Barney Smith on 0191 384 8905 or email bsmith@ckscience.co.uk. Please quote reference DH23591 in all correspondence.
As reported by Chemical and Engineering News, the leading Biotechnology company, Amgen and biopharmaceutical company, Celgene are making steps to strengthen their oncology drug pipelines through acquisitions.
Amgen:
Amgen is set to pay $1.2 for Micromet, an innovative biopharmaceutical company which concentrates on developing oncology drugs. Their technologies focus on antibody technology (BiTE) which work by binging both tumour cells and T cells which causes the cancer cell to die.
Celgene:
Celgene is acquiring Avila Therapeutics for $925 million. Avila are the first company to design and develop targeted covalent drugs robustly. These drugs are able to both inhibit and silence disease-causing proteins.
Graeme Pallas at CK Science is currently recruiting for two QA Specialists to join a multi national pharmaceutical company to work with them on initially a temporary contract until the end of 2012.
The successful candidate for this QA Specialist role will be responsible for driving a quality culture throughout site ensuring that products and services meet the necessary regulatory requirements. In addition, you will support the maintenance and operation of the quality system including change control, deviations and CAPA. You may also participate in both internal and external audit programmes.
As a QA Specialist you will be qualified in a life sciences subject and or/or have demonstrable experience working in the quality assurance function of a manufacturing organisation.
For more information or to apply for this QA Specialist role please contact Graeme Pallas on 0191 384 8905 or email gpallas@ckscience.co.uk. Please quote reference DH23588in all correspondence.
Pharmiweb has reported that Almac has achieved success in MHRA inspections at both their Craigavon Headquarters, Northern Ireland and Elvingston, Scotland sites. These inspections were the first biennial audits to confirm continued compliance with Investigation Medicinal Products (IMP) licenses and GMP certificates.
The first inspection audited Almac’s isotope laboratory facility in support of their IMP license. Following the MHRA’s acceptance of Almac’s response report, Almac’s licence will be applicable to both radiolabelled and non-labelled IMPs. The second inspection covered Almac’s analytical laboratory in Elvingston, Scotland, supporting its GMP certificate as a contract analytical facility.
The Inspector complimented the analytical team on their professionalism and laboratory high standards. As a result of this successful audit, two GMP certificates will be issued for human and veterinary applications.
President and Managing Director, Stephen Barr commented on the successful audits saying:
“We are delighted with the outcome of these inspections. It is reassuring to know that the value we place on our staff and facilities is recognised in this way, and adds further credibility to our wealth of experience and services we offer.”
Hannah Milward is currently seeking to recruit a Process Improvement Manager to join a major healthcare organisation.
As a Process Improvement Manager you will provide focus on the development of new and existing processes. By building quality in to the process design, the products will be produced in the most efficient way and meet the customer and regulatory needs.
As a Process Improvement Manager you will be responsible for leading the Process Improvement Team to provide an efficient service to optimise manufacturing and cleaning processes using a quality by design approach whilst ensuring the validation activities meet Regulatory and Customer requirements.
The job holder will need to provide an effective New Product Introduction service for Clinical Trial clients to ensure new products are introduced successfully and that the processes are developed and validated to ensure the required levels of product quality and regulatory compliance are met. You will also need to deliver a comprehensive process, equipment and cleaning validation programme in accordance with cGMP and Customer requirements.
To be considered for this Process Improvement Manager position you will have:
You will also enjoy working cross functionally in a fast paced environment with teams of diverse people, have a can do attitude with the capability to plan and see the bigger picture, excellent Leadership and Customer Service skills and the ability to influence and build relationships at all levels across the business.
For more information or to apply for this role please contact Hannah Milward on 0114 283 9956 or email hmilward@ckscience.co.uk. Please quote reference SH23326 in all correspondence.